Evaluation of new putative tumor markers for melanoma

Annals of Surgical Oncology

Volumn 3, Issue 6, 1996, Pages 558-563

  Reintgen, Douglas ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Metastatic melanoma; Prognosis; Tumor marker

Indexed keywords

LIPID; LIPID ASSOCIATED SIALIC ACID; LIPID-ASSOCIATED SIALIC ACID; N ACETYLNEURAMINIC ACID; PROTEIN S 100; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; FOLLOW UP; HUMAN; MALE; MELANOMA; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; SKIN TUMOR; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPIDS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; N-ACETYLNEURAMINIC ACID; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; S100 PROTEINS; SKIN NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0030276648     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02306089     Document Type: Article

References (5)

1. Schutter EMJ, Visser JJ, van Kamp GJ, et al. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy: a review of the literature. Tumor Biol 1992;13:121-32.
2. Katopodis N, Hirshaut Y, Geller ML, Stock CC. Lipid-associated sialic acid test for the detection of human cancer. Cancer Res 1982;42:5270-5.
3. Reintgen DS, Cruse CW, Wells KE, Saba HI, Fabri PJ. The evaluation of putative tumor markers for malignant melanoma. Ann Plast Surg 1992;28:55-9.
4. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965;19:739-44.
5. Nakajima T, Watanabe S, Sato Y, Kameya T, Shimosato Y, Ishihara K. Immunohistochemical demonstration of S-100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer 1982;50:912-18.